First-time drug launchers are expected to account for more than half of the blockbuster therapies launched over the next 5 years. Surprisingly, 67% of first product launches fail to reach pre-launch forecasts.1 So, how do you plan for optimal success?
At the core of designing and executing a successful commercial launch strategy is having the right data and insights to effectively plan, execute, and adapt quickly to the market. Medidata Acorn AI Commercial Data Solutions has supported 40% of the first-time drug launches in the US so far in 2021. This webinar will address the six critical factors to consider for a successful commercial launch strategy:
 Source: EvaluatePharma by Evaluate; March 2020; McKinsey analysis"
Frank Lane is a Vice President of Commercial Data Solutions at Medidata Acorn AI, a Dassault Systèmes company. Frank is responsible for client value management across commercial and delivery groups. Frank joined Medidata through the acquisitions of SHYFT Analytics in 2018. Frank was a founder of SHYFT in 2003 and he held leadership positions across all client engagement functions.
Joe Shankey is a Customer Success Lead at Medidata Acorn AI, a Dassault Systèmes company. Joe has spent his career partnering with biotech companies to improve their use and consumption of data analytics, optimize their marketing spend, and configure commercial data solutions to support new drug launches. Joe graduated Binghamton University with a degree in Integrative Neuroscience.
Vinny Marino is the Senior Director of Delivery Excellence, leading the Commercial Data Solutions team at Medidata Acorn AI, a Dassault Systèmes company. Vincent has spent the majority of his career helping biotech companies successfully commercialize specialty medicines through use of data and analytics. Vincent graduated from Boston College with a degree in Economics.